Work

Ibrutinib plus blinatumomab in Relapsed/Refractory B-cell acute lymphoblastic leukemia: Results of A phase 2 study

Year: 2025

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2025-3356

Authors: Brian Jonas, Mehrdad Abedi, Aaron Rosenberg, Naseem Esteghamat, Rasmus Hoeg, Lihong Qi, Eric Tam, Joseph Tuscano, George Yaghmour

Institutions: University of California Davis Medical Center, University of California, Davis, University of Southern California, USC Norris Comprehensive Cancer Center

Language: English

Topic: Acute Lymphoblastic Leukemia research

Subfield: Public Health, Environmental and Occupational Health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7108482841

Cites:

Cited by:

Related to: